Remantadin-КR (rimantadine) tablets 50 mg. №20

$2.70

Manufacturer: Ukraine

Purpose: Blocks viral replication to treat and prevent influenza A.

SKU: MED60917 Categories: ,

Description

Remantadin-КR (rimantadine) tablets 50 mg. №20

Ingredients

Active ingredient: Rimantadine hydrochloride 50 mg per tablet.

Dosage

Recommended dosage: The usual dose is 50 mg once or twice daily as directed by a healthcare professional.

Indications

Indicated for: Prevention and treatment of influenza A virus infections.

Contraindications

Do not use: In patients with a known hypersensitivity to rimantadine or any other component of the product.

Directions

– Take with food to reduce stomach upset.
– Do not crush or chew the tablets; swallow them whole with a full glass of water.

Scientific Evidence

Rimantadine, the active ingredient in Remantadin-КR tablets, is a viral replication inhibitor that works by blocking the ion channel formed by the M2 protein of the influenza A virus. This mechanism prevents the release of viral RNA into the host cell, thereby inhibiting viral replication.

Several studies have demonstrated the efficacy of rimantadine in both the prevention and treatment of influenza A infections. A study published in the Journal of Antimicrobial Chemotherapy found that rimantadine significantly reduced the duration and severity of influenza symptoms compared to a placebo.

Additional Information

– Store at room temperature away from moisture and heat.
– Keep out of reach of children.
– If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Overall, Remantadin-КR tablets containing rimantadine are a valuable option for the prevention and treatment of influenza A infections. The drug’s mechanism of action, supported by scientific evidence, makes it a reliable choice for healthcare providers in managing influenza outbreaks.

Clinical trials have shown that rimantadine is well-tolerated and effective in reducing the duration of illness and viral shedding in patients with influenza. Its comparative effectiveness against similar drugs makes it a preferred choice in certain populations, especially in cases of influenza outbreaks or for prophylactic use in high-risk individuals.